HUNTINGDON VALLEY, Pa.--(BUSINESS WIRE)--Immunicon Corporation (NASDAQ-NM:IMMC) announced today that President and Chief Executive Officer Byron D. Hewett and Chief Financial Officer and SVP of Finance & Administration James Murphy are scheduled to present at the 2006 UBS Global Life Sciences Conference on Thursday, September 28, 2006 at 9:30 a.m. The presentation will focus on Immunicon's products and will update investors and other interested parties regarding the most recent activities at the Company. The conference, to be held at the Grand Hyatt in New York City, September 25-28, 2006, will provide insight for investors, CEOs and other senior level executives on biotechnology, life sciences, medical technology and pharmaceutical fields.
